WallStSmart
YI

111 Inc

NASDAQ: YI · HEALTHCARE · MEDICAL DISTRIBUTION

$5.77
+1.27% today

Updated 2026-06-05

Market cap
$38.71M
P/E ratio
P/S ratio
0.00x
EPS (TTM)
$-7.63
Dividend yield
52W range
$2 – $9
Volume
0.0M

WallStSmart proprietary scores

21
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
6.3
Quality
B
2.0
Profitability
F
5.0
Valuation
C+
4/9
Piotroski F-Score
Moderate
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$5.96
+3.29%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Debt/equity -0.38x — low leverage
Risks
- Thin margins at -0.53%
- Negative free cash flow $-91.72M
- Revenue declining -26.70% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$13.52B$14.95B$14.40B$12.21B$12.56B
Net income$-416.88M$-392.69M$-64.74M$-16.84M$-37.04M
EPS$-7.63
Free cash flow$-54.73M$-457.07M$247.82M$114.69M$-91.72M
Profit margin-3.08%-2.63%-0.45%-0.14%-0.53%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
YI$38.71M212.72.05.06.3Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

111 Inc trades at $5.77. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $12.56B. with profit margins at -0.53%.

Frequently asked questions

What is 111 Inc's stock price?

111 Inc (YI) trades at $5.77, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is 111 Inc overvalued?

111 Inc carries a Smart Value Score of 21/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of 111 Inc (YI)?

The 12-month analyst consensus target is $5.96, about 3.3% above the current $5.77. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

What is 111 Inc's revenue?

111 Inc's trailing twelve-month revenue is $12.56B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Company info

SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryChina
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.00x
ROE-7.57%
Beta0.66
50D MA$6.08
200D MA$5.46
Shares out0.01B
Float0.09B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years